Riociguat Johnson Francis | February 14, 2024 | General Cardiology | No Comments Related Posts Aprocitentan the first endothelin receptor antagonist approved for treatment of hypertension No Comments | Mar 22, 2024 Mechanical vs. Bioprosthetic Heart Valves: Choosing the Right One for Your Patient No Comments | Jan 17, 2026 Heart rate as a risk factor in cardiovascular disease No Comments | Dec 6, 2009 Discontinue prasugrel 7 days before surgery – Recovery Trial No Comments | Jun 21, 2012 About The Author Johnson Francis Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal